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ABSTRACT
Toxoplasma gondii is a highly successful protozoan
parasite in the phylum Apicomplexa, which contains
numerous animal and human pathogens. T.gondii
is amenable to cellular, biochemical, molecular and
genetic studies, making it a model for the biology
of this important group of parasites. To facilitate
forward genetic analysis, we have developed a high-
resolution genetic linkage map for T.gondii. The gen-
etic map was used to assemble the scaffolds from a
10X shotgun whole genome sequence, thus defining
14 chromosomes with markers spaced at 300 kb
intervals across the genome. Fourteen chromosomes
were identified comprising a total genetic size of
592 cM and an average map unit of 104 kb/cM.
Analysis of the genetic parameters in T.gondii
revealed a high frequency of closely adjacent, appar-
ent double crossover events that may represent gene
conversions. In addition, we detected large regions of
genetic homogeneity among the archetypal clonal lin-
eages, reflecting the relatively few genetic outbreed-
ing events that have occurred since their recent
origin. Despite these unusual features, linkage
analysis proved to be effective in mapping the loci
determining several drug resistances. The resulting
genome map provides a framework for analysis of
complex traits such as virulence and transmission,
and for comparative population genetic studies.
INTRODUCTION
Toxoplasma gondii is a widespread protozoan parasite that is
capable of infecting nearly all species of warm-blooded ver-
tebrates. While infections are common, disease typically only
develops in rare situations such as immunocompromised hosts
or during pregnancy (1). A member of the phylum Apicom-
plexa, T.gondii is closely related to a number of animal patho-
gens (Eimeria, Neospora, Sarcocystsis) and human pathogens
(Cyclospora, Cryptosporidium, Plasmodium) (2). Due to the
ease of genetic manipulation, robust animal models, and
facility for cellular and biochemical studies, T.gondii has
emerged as a model system for studying the unique biology
of apicomplexan parasites (3–5).
T.gondii has an unusual population structure that consists of
three predominant clonal lineages (types I, II and III) (6,7).
Only two alleles exist at each locus and the distribution of
these among the three lineages indicates that the majority of
extant strains originated from a single recombination event
and that since this, they have undergone a limited number
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of genetic outbreeding events in the environment (8,9).
T.gondii has a typical heteroxenous (alternating, two host)
coccidian life cycle, consisting of asexual replication of hap-
loid stages in a variety of warm-blooded hosts and a sexual
cycle that only occurs in the enterocytes of the cat intestine
(10). Following sexual development, oocysts are shed into the
environment and from here they can contaminate food and
water, thus infecting a variety of intermediate hosts. Meiosis
occurs in the environment following shedding, and results in
eight haploid progeny called sporozoites that remain contained
within the oocyst. The separate maintenance of the three clonal
lineages in the wild may result from two unusual features in
the life cycle. First, a single organism is capable of undergoing
the complete sexual development and self-fertilization in the
cat to yield infectious oocysts (11,12). This trait is not unique
to T.gondii as it is probably expressed by most apicomplexans.
However, combined with the relative infrequency of simul-
taneous infection with more than one strain in cats, this may
limit the opportunities for genetic recombination. Second, the
direct oral infectivity of T.gondii tissue cysts for other inter-
mediate hosts is highly unusual and allows transmission with-
out the need of the sexual cycle. Evidence suggests that this
is a recent phenomenon that arose simultaneously with the
recombination event(s) that created the three predominant
clonal lineages (9).
The ability of T.gondii to undergo meiosis in the cat has
been exploited to develop experimental genetic approaches
based on co-infection of a cat with tissue cysts from two
separate parasite strains (13). These initial genetic crosses
revealed the capacity of clones of the type III lineage to both
self-fertilize and to cross-fertilize at roughly equal frequencies
(13). Subsequently, genetic crosses have been done between
the type II and III lineages (14) and more recently between the
type I and III lineages (15). Before undertaking the present
work, the genetic linkage map for T.gondii consisted of
57 unique genetic markers that defined 11 different chromo-
somes (linkage groups) (14,15). While these studies established
the feasibility of linkage mapping as a forward genetic analysis
in T.gondii, they were limited by the low resolution of
the genetic map, the absence of a corresponding physical
map, and relatively fragmentary sequence information.
Large-scale sequencing of expressed sequence tags (ESTs)
in T.gondii has been useful for gene discovery and to identify
a large number of single-nucleotide polymorphisms (SNPs)
between different lineages (16–18). We have used the
extensive EST database established for T.gondii to define
SNPs that identify strain-specific alleles in T.gondii. Herein,
we report on the segregation analysis of 250 genetic markers
that detect SNPs between 71 recombinant progeny from
several different genetic crosses. Linkage analysis was used
to establish a robust genetic map and to assemble the
scaffolds from a 10X genome sequencing project into a com-
posite genome map for T.gondii.
MATERIALS AND METHODS
Genetic crosses
Recombinant progeny were obtained from a genetic cross
called c96 that was performed by crossing the PTG strain
(a type II strain derived from ME49 by cellular cloning)
that was resistant to arprinocid-N-oxide (ANO) and
5-fluorodeoxyuridine (FUDR) with the CTG strain (Type
III) that was resistant to sinefungin (SNF), adenine arabinoside
(ARA-A) and diclazuril (DCL). Parental mutant strains were
constructed using methods described previously (13,19–21).
The c96 cross was performed by co-infecting a single cat with
tissue cysts of the two different parental strains of the parasite
after propagation of tissue cysts in mice. Oocysts were col-
lected following shedding, allowed to sporulate, and then used
to infect monolayers of human foreskin fibroblasts (HFF
cells). Recombinants were selected in bulk by culture in the
presence of both SNF (3 · 107 M) and ANO (3.6 · 105 M),
and then cloned by limiting dilution in the absence of drugs.
We also isolated new clones from a previously described
cross between the type I strain GT-1 and the type III strain
CTG (15). This cross was originally performed in two separate
animals, numbered C285 and C295. We have previously
reported on the segregation of alleles in 26 progeny of the
C295 cross (15): 20 of these were genetically distinct and were
used here. We isolated 11 new clones from the C285 cross by
limiting dilution on HFF monolayers. Clones were genotyped
using a set of PCR markers and unique recombinant clones
chosen for further analysis. Recombinant progeny were pheno-
typed for resistance to the drugs FUDR (1 · 105 M), SNF
(3 · 107 M), ARA-A (3 · 104 M) or ANO (3.6 · 105 M)
by growth on HFF monolayers. Following inoculation at an
MOI of 1:1, growth was followed microscopically to evaluate
the percentage of cells infected, the extent of replication (2, 4,
8, 16 cell stages) and the degree of lysis following culture for
48–72 h. Clones were scored as sensitive versus resistant based
on comparison to wild-type parasites and parental strains that
were resistant to specific drugs. Although diclazuril was used
on one of the crosses (c96), progeny were not tested for
sensitivity to this drug.
Marker development and analysis
We utilized a previously defined collection of 57 genetic
markers that define restriction length polymorphisms
(RFLPs) that were analyzed by PCR amplification followed
by restriction digestion and gel electrophoresis (15). Addition-
ally, we converted a number of cosmid clones that distinguish
RFLPs by Southern blotting (14) to PCR-based analysis. The
majority of these cosmid clones contained genomic inserts
from the type I RH strain. End sequences of these cosmid
clones were compared by BLASTN to the genomic sequence
of the ME49 strain (Type II) (http://toxodb.org/ToxoDB.
shtml) to identify SNPs. Primers were then designed to amp-
lify regions flanking SNPs that also detected strain-specific
RFLPs. Fourteen of these provided reliable markers and these
were given the prefix of KT followed by the original marker
name in Figure 1.
To identify additional markers, we analyzed the T.gondii
EST assemblies (http://www.cbil.upenn.edu/apidots/), which
contain sequences generated from all three parasite lineages.
Polymorphisms were identified by comparison of ESTs from
assemblies that contained two or more overlapping sequences
from two or more strain types. The resulting SNPs were then
mapped against the 10X scaffold assemblies of the T.gondii
genome derived from the type II strain ME49 (http://toxodb.
org/ToxoDB.shtml) using BLASTN to identify corresponding
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genomic regions. We also utilized a specially designed
database that systematically maps the distribution of poly-
morphism found in the ESTs against the genome (http://
boothroydlab.stanford.edu/snp_maps/).
In regions where the EST abundance was not sufficient to
identify SNPs, we amplified genomic regions from the three
lineages, sequenced and aligned them to identify new poly-
morphisms. Triplicate PCR reactions were conducted from the
RH strain (type II), the ME49 strain (type II) and the CTG
strain (type III). Amplicons were sequenced using BigDye 3.0
cycle sequencing (ABI). Resulting sequences were aligned in
clustal X and polymorphisms scored based on a consensus
of two out of three templates. SNPs were identified by com-
parison of the consensus sequences for each of the three
lineages.
Once SNPs had been identified in silico, they were screened
for whether they detected RFLPs in the type strains RH (type
I), ME49 (type II) and CTG (type III). Flanking regions were
amplified by PCR and the resulting amplicons were subjected
to restriction digestion and gel electrophoresis. In general, the
regions chosen for final amplification of each marker range
from 200 to 600 bp, and flank a single SNP that defined an
informative RFLP. Markers were analyzed by PCR amplifica-
tion, restriction gel digestion and agarose gel electrophoresis
in the presence of ethidium bromide. Specific information on
each of the markers including primers, PCR conditions and
RFLPs can be found at http://ToxoMap.wustl.edu/.
MAPMAKER and linkage analysis
Genetic linkage maps were generated using MAPMAKER/
EXP 3.0 (22). In total, 71 recombinant progeny were analyzed
using a combination of the 250 genetic markers (excluding
drug resistance markers) as shown in Table 1. The data from
all three crosses were combined into a single analysis by
denoting which marker/progeny combinations were informat-
ive. These data were analyzed in backcross configuration, as
appropriate for the haploid inheritance system of the T.gondii
crosses. An LOD value of >3.0 was used as a minimum
cut-off to assign linkage. Drug resistance phenotypes were
Figure 1. Representative SNP–RFLP marker used in mapping analysis. Data for the marker cB21-4, indicating primers, PCR conditions, the sequence flanking the
SNP and an example of the alleles detected (gel insert). The specific SNPs detected are indicated in parentheses within the sequence block using the following format
(allele type I, allele type II and allele type III). While most markers define simple biallelic patterns, in some cases these differences occur closely spaced in the
genome. This example illustrates two closely spaced SNPs, one unique to type II and one unique to type I, thus this marker is capable of distinguishing all three
genotypes using a combination of restriction enzyme digestions. The slightly larger band in the undigested fragment of the type III strain is due to an 8 bp difference;
however, this is not the basis for the SNP differences detected here. Data for the complete set of markers can be found at http://ToxoMap.wustl.edu/.
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analyzed from the progeny of I · III cross using MapManager
QTX (23) to detect maximum single locus associations (using
the ‘near’ function which provides a LOD score for the peak
association).
Genome-wide associations of drug resistance phenotypes
The sensitivity versus resistance phenotypes for SNF, FUDR
and ARA-A were coded as 0 or 1 for the 31 progeny of I · III
cross and evaluated for association with all markers typed in
this cross on all chromosomes. Log likelihoods were determ-
ined by 1000 random permutations using the discrete small
sample statistics previously developed for evaluating quantit-
ative SNP associations in the haploid inheritance system of
Plasmodium falciparum (24). This method allows for the
detection of deviations from simple Mendelian inheritance
if present, e.g. effects of incomplete penetrance, epistasis or
multiple co-epistatic determinants. Such effects are consistent
with two-state phenotypes as well as traits showing continuous
variation. Empirical significance thresholds were determined
using second-order nested permutations: 1.7 (‘marginally sig-
nificant’) and 3.0 (‘highly significant’). This analysis accounts
for (i) any segregation distortion caused by drug selection or
other factors, (ii) the non-normality of the permutation distri-
butions and (iii) the multiple tests of these multi-locus scans.
Double crossover analysis
To compare the observed frequencies of double-crossovers at
different spacings with the distribution expected from random
models of crossover events, we used a modified form of the
statistics of count-location processes (25). This treatment is
based on multiple Poisson models and can reveal biases caused
by general crossover interference, local crossover clustering
or local gene conversions, which give various patterns of
significant deviations from the random models. For a similar
analysis of a P.falciparum cross (26), the number of interven-
ing markers between double-crossovers was tallied by class
(i.e. one intervening marker, two intervening markers, etc.)
across all chromosomes. However, such tallies are not robust
for analysis of the three T.gondii crosses because of substantial
heterogeneities in marker densities and recombination fre-
quencies among the crosses and among chromosomes. Instead,
we calculated or estimated the physical map lengths of all
inter-marker intervals from the coordinates of markers on
the sequenced contigs and ordered scaffolds (examples of
such coordinates are shown in Figure 6 and complete data
are found at http://ToxoMap.wustl.edu/). Upper and lower
bounds for distances spanned by each double crossover (DU
and DL) were calculated as the ranges of the physical lengths
that respectively include and exclude the inter-marker inter-
vals containing the pair of crossovers. Then, for the analysis
shown in Figure 5B, the best estimate of each inter-crossover
distance was taken to be DL + (DU  DL)/3. This is the mean
value, with variance (DU  DL)/18, for a null model of uni-
formly distributed crossover locations in the local region
containing the double crossover.
Separate models were made for each jth chromosome, based
on the total number of crossovers observed in the three crosses
combined. Physical distances were binned into fixed-length
segments (1000/3 kb for the analysis shown in Figure 5B), then
the probability pj,k of two crossovers on chromosome j being
separated by k such segments was given by
pj‚ k ¼
2 njk
 
nj nj þ 1
  ‚
where (nj + 1) is the number of the fixed-length segments,
including the partial end segment, on chromosome j. Thus,
nj(nj + 1) is the size of the state space of physical segments
within which double crossover events can be observed. This
treatment assumes an average genetic marker density of at
least one per physical segment, which determined the choice
of 1000/3 kb segment lengths for analysis of the three com-
bined crosses. Then the total expected number, Xk of double-
crossovers separated by k intervals was given by
Xk ¼
X14
j¼1
Vjpj‚ k‚
where Vj is the double crossover number for chromosome j.
Vj can be the total observed counts of double crossovers, or
may be based on alternative definitions or models of double-
crossover events as for the comparison of the two ‘Expected’
lines in Figure 5B. Where k > (nj + 1), Vj pj,k was set to zero,
ensuring that the shorter chromosomes contribute to the total
Xk only up to their maximum number of segments. The prob-
abilities of obtaining the observed numbers of events from the
random/uniform null model (as shown on the two deviant left
hand bars of Figure 5B) were calculated from the Poisson
mixture density using appropriate chromosome-specific
Vj pj,k parameters estimated for each individual chromosome.
Mapping BAC-ends
The T.gondii ME49 (B7 clone, type II genotype) genomic
BAC library was constructed by cloning size-selected Sau3AI
partial digest fragments into pBACe3.6 digested with
BamHI (27). Clones were randomly selected for end sequen-
cing (http://www.sanger.ac.uk/Projects/T_gondii/). Of 10 329
Table 1. Summary of genetic crosses and markers used in assembly of the
T.gondii genome map
Parental
types
Crosses Name of
crossa
Number of
progeny
Number of
markers
II · III ME49 (B7 clone) ·
CTG ARA-Ar/SNFr
S
CL
10b
9b
135
PTG FUDRr ANOr ·
CTG ARA-Ar/SNFr/DCLr
c96 21b 135
I · III GT-1–F3 FUDRr ·
CTG ARA-Ar/SNFr
C285
C295
11c
20b
176
Total 71 253d
aSeparate crosses were done in parallel animals using mixtures of the indicated
parental strains for CL and S (14), and for C285 and C295 (15).
bClones were selected by drug resistance. Drug concentrations used for selection
and typing of recombinants: ARA-A; adenine arabinoside (3 · 104 M);
SNF; sinefungin (3 · 107 M); FUDR; 5-fluorodeoxyuridine (1 · 105 M);
ANO; arprinocid-N-oxide (3 · 105 M); DCL: diclazuril (not tested).
cClones were randomly selected.
dIn addition to 250 unique genetic markers, three drug resistance markers were
used in constructing the maps. The total number of markers is not simply the sum
of the values for each cross separately as some markers are used in both crosses,
while others are valid for only one of the crosses.
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reads, 4381 BAC-end sequence pairs were individually
aligned to genomic scaffold sequences using BLAT (28).
To be considered further, both members of a given end
sequence pair were required to (i) achieve an alignment sig-
nificance score >400 bits, (ii) include >80% or more of their
length in the alignment and (iii) have only one such reliable
alignment found in the entire genome. A total of 1616 BAC-
end sequence pairs satisfied these requirements, and their
BLAT-identified genomic locations were used to inform
and augment the genetic mapping study.
CMap database for T.gondii
The CMap application was established on an OSX v10.3 plat-
form running UNIX and using the source code and instructions
provided by the developer (http://www.gmod.org/cmap/index.
shtml). Data were housed in a MySQL database and interfaces
created with Perl 5.8 and Apache v2.0. CMap for T.gondii was
built by including all of the data for genetic linkage maps with
physical placement of markers on the scaffolds and assembled
chromosomes. Correspondences were drawn between the
same marker on each of the maps to establish relationships
between the physical and genetic distances. CMap for T.gondii
is housed at http://ToxoMap.wustl.edu/cmap/.
RESULTS
Genetic crosses used in construction of the map
We analyzed the segregation of polymorphic DNA markers
among a total of 71 progeny from genetic crosses that were
performed between type II and III lineages or between the type
I and III lineages as shown in Table 1. A total of 19 progeny
were included from a previously described cross between the
type II strain PTG and the type III strain CTG (14). We also
obtained 21 new clones from a separate cross that was also
performed using the parental strains PTG and CTG (referred to
as c96 cross, Table 1). In both cases, the progeny were selected
by virtue of drug resistance mutations engineered into the
parental strains (Table 1), as described previously (21). The
frequency of self-mating in these crosses was previously found
to be 50% (21), and recombinant progeny can be reliably
distinguished by virtue of drug resistance or sensitivity.
Additionally, we analyzed 20 progeny from a previously
described cross between the virulent type I lineage strain GT-1
and the non-virulent type III lineage CTG (15). In contrast to
the previously described clones that were isolated by drug
selection, the new clones from this cross were randomly selec-
ted in the absence of drug selection. Of 95 separate clones that
were screened using a combination of 11PCR markers located
on different chromosomes, all but one was a recombinant: the
sole parental strain was of the type III lineage (data not
shown). Eleven of these newly isolated clones were genetic-
ally distinct, and they were included in the analyses here
(Table 1).
Development of SNP–RFLP markers
Initially, we utilized a previously defined collection of 57
genetic markers that detect restriction fragment length
polymorphisms (RFLPs). Markers were analyzed by PCR
amplification followed by restriction digestion and gel
electrophoresis (PCR–RFLP typing) (15). These markers
were placed on the genome by comparison of their sequences
with BLASTN against the recently completed 10X shotgun
coverage of the T.gondii genome that has been assembled into
scaffolds (available at http://toxodb.org/ToxoDB.shtml). A
single best alignment resulted in unambiguous placement of
all of these markers and it also identified many physical
regions that were not represented by this collection of markers
(data not shown). To expand the coverage of genetic markers,
we placed new markers at approximately regular intervals
along all of the 10X scaffolds that were 50 kb or greater in
size. These markers were developed using the extensive EST
database of T.gondii (17,29) to identify SNPs between differ-
ent strains. In total, 200 new RFLP markers were charac-
terized, providing a total of 250 markers spaced at 300 kb
intervals across the genome. A complete listing of these mark-
ers, including methods for their analysis is contained in a
genetic mapping database for T.gondii (http://ToxoMap.
wustl.edu/). An example of the data supplied for each marker
is provided in Figure 1 including primer sequences, PCR con-
ditions, detection of the alleles by gel electrophoresis, the
flanking sequence and specific SNP(s) detected.
Generation of linkage maps using MAPMAKER
For the three predominant strains of T.gondii, each locus con-
tains only two alleles, thus two lineages share one genotype
with the third containing a distinct allele often defined by a
single SNP. Consequently, the number of informative markers
differs for the various genetic crosses, as listed in Table 1. Type
I-specific SNPs are informative only in the I · III crosses, and
type II-specific SNPs are informative in only the II · III
crosses, while type III-specific SNPs are informative in both
genetic crosses. Progeny listed in Table 1 were analyzed by
PCR amplification of the appropriate genetic markers followed
by restriction enzyme digestion and agarose gel electrophor-
esis to detect specific SNPs. A database containing the segrega-
tion data for all of the progeny and markers used in the present
analysis can be found at http://ToxoMap.wustl.edu.
The inheritance of SNP–RFLP markers among the progeny
was compared using MAPMAKER (22) to generate linkage
maps with a minimum LOD score of >3.0. Eight major link-
age groups were identified by MAPMAKER in the absence of
any specific pre-assignments (data not shown). One of these
groups resulted from the combination of markers on chromo-
somes Ib, III, VI, IX, X and XII, reflecting a bias in shared
alleles among these chromosomes. Additionally, markers on
chromosomes VIIb and VIII were grouped together. Specific
anchors for each chromosome were then assigned for each
chromosome. These anchors were chosen based on the fol-
lowing criteria: (i) their use in previous studies defining the
segregation groups (14,15), (ii) their hybridization to specific
chromosomes separated by pulse-field gel electrophoresis
(PFGE) [(30) and data not shown] and (iii) their physical
assignment to specific scaffolds of the 10X genome as estab-
lished by BLASTN. When specific anchors were assigned
(Table 2), MAPMAKER resolved the markers into 13 discrete
linkage groups. The placement of each marker was supported
by a predominant LOD score (generally >6.0) that was also
consistent with the physical location on the scaffolds of the
10X genome. Although the LOD scores indicated possible
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secondary linkage between Ib and IX and XII, this artifact is
attributable to strong segregation distortion: non-linkage
among these separate chromosomes was confirmed using per-
mutation analysis (data not shown). For these three chromo-
somes, the progeny show a highly significant excess of the
type III CTG parental alleles (80:20 ratio instead of the
expected 50:50, P < 0.001). This can be attributed to drug
selection on IX and XII but the cause for Ib is unknown.
MAPMAKER was unable to separate two chromosomes,
VIIb and VIII, due to the fact that some markers on the distal
end of scaffold 995362, which lies on chromosome VIII (i.e.
AK46, AK47, AK111, AK112), were linked to chromosome
VIIb while other markers were linked to both chromosomes
(i.e. AK49, SRS1, SAG1.c, SRS2 on scaffold 995362, and
markers AK50, AK51 on scaffold 995368). The remaining
markers on scaffold 995368 were linked only to chromosome
VIII (i.e. AK52, AK30, SAG2, etc.). The individual assem-
blies for each of these scaffolds (derived from the type II strain
ME49) were rechecked and found to be valid, indicating that
this apparent linkage is not due to an error in the physical maps
(data not shown). This apparent linkage is entirely attributable
to the results of the I · III cross because both VIIb and VIII
show a preponderance of type I SNPs (colored red in Figure 2)
(1), and analysis of the three crosses separately showed strong
statistical significance for VIIb versus VIII marker associ-
ations only in the I · III cross (log likelihoods estimated
from 1000 permutations were between 4.9 and 7.1), but not
in the II · III crosses (2). PFGE does not resolve the question
of possible physical linkage between VIIb and VIII since these
individual chromosomes are each >5 Mb in size (the current
resolution of our gels) and expected to remain trapped in the
well. This raises the possibility that chromosomes VIIb and
VIII are physically linked in the type I GT-1 parent; however,
considering these results together, we have elected to report
these two groups as separate chromosomes. The corresponding
14 linkage groups including the positioning of all 250 genetic
markers and three drug resistance markers are shown as
ordered genetic maps in Figure 2.
Table 2. Assignment of markers to specific chromosomes and recombination
rates for each chromosome
Chromosome
number
Anchoring markers
in MAPMAKER
Genetic
size (cM)a
Physical
size (bp)b
Average map
unit (kb/cM)
Ia AK1 43.9 1 856 182 42.3
Ib ACT1 16.2 1 956 324 120.8
II L351 17.9 2 343 157 130.9
III CB21-4 34.9 2 470 845 70.8
IV Bc18U 38.5 2 576 468 66.9
V L358 28.4 3 147 601 110.8
VI PK1 29.3 3 600 655 122.9
VIIa SAG4 30.1 4 502 211 149.6
VIIb L339 32.4 5 023 822 155.1
VIII GRA1/AK113 64.7 6 923 375 107.0
IX BTUB 59.2 6 384 456 107.8
X C19-TA3 68.3 7 418 475 108.6
XI GRA4 50.9 6 570 290 129.1
XII SAG3 77.8 6 871 637 88.3
592.5 61 645 498 Ave. 104.0c
aTotal genetic units as determined by MAPMAKER (Figure 2).
bTotal physical size obtained by summing the individual scaffolds (Figure 4).
cCalculated based on the sum of mapped scaffolds.
Figure 2. Genetic linkage maps for the 14 chromosomes of T.gondii. Individual markers are shown to the right of the vertical bar and chromosome numbers are given
above each map. Markers that map to the same node are indicated to the right of a solid vertical bar. The corresponding genetic distances between each node are given
to the left of each map and the total sizes in cM are shown at the bottom of each chromosome. Polymorphisms that are unique to type I are shown in red, those unique to
type II are shown in green, those unique to type III are shown in blue and markers that contain multiple polymorphism as illustrated in Figure 1 are shown in yellow.
Maps were constructed using MAPMAKER (22) from the analysis of 71 recombinant progeny using 250 genetic markers (Table 1). Markers that include data
analyzed by Southern blot are followed by the suffix ‘.c’.
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Mapping drug resistance
To illustrate the utility of linkage analysis in mapping specific
drug resistance traits in T.gondii, we have depicted the asso-
ciation between each marker and resistance to SNF, FUDR or
ARA-A across the entire genome (Figure 3). Resistance to
each of these compounds showed a single strong association
with log-likelihood ratios of >6.0 and an absence of strong
secondary associations (Figure 3). We have not attempted to
measure the levels of resistance in each clone quantitatively,
and it is possible that with more precise estimates of their IC50
values, secondary traits influencing susceptibility would be
detected. However, as these compounds are used here as an
experimental tool only and are not clinically relevant, they
serve here as an example of mapping simple Mendelian traits.
The resolving power of these associations, when considered
as a proportion of chromosome length, is similar to that
obtained previously in the 35-progeny Dd2 · HB3 cross of
P.falciparum [compare Figure 3 with (31,32)]; however, the
physical distances resolved are 6-fold greater in T.gondii
because of the lesser meiotic crossover frequency.
The target of two of these drugs is known from previous
studies. FUDR targets the uracil phosphoribosyl transferase
(UPRT) gene and mutations in this target are resistant to
growth inhibition (33,34). Similarly, ARA-A targets adenos-
ine kinase (AK), a non-essential enzyme involved in purine
salvage (35,36). These known targets provide an estimate of
the precision of mapping by linkage analysis. The UPRT gene
is in the center of chromosome XI and mapping of the resist-
ance phenotype revealed perfect correspondence to this locus
in I · III and c96 crosses (Table 3; Figures 2 and 3). The AK
gene lies at the end of chromosome XII and mapping of
resistance to ARA-A revealed perfect correspondence to
this locus in I · III cross (Table 3; Figures 2 and 3). Because
informative markers in the II · III crosses do not lie at exactly
the same intervals (there is no informative polymorphism
associated directly with the AK gene), resistance to ARA-A
was mapped to a relatively broad region spanned by the mark-
ers AK165 and AK163.
The biochemical targets of the remaining two inhibitors
used here are unknown. The compound SNF is an analog
of S-adenosyl-methionine and the mechanism of action is
thought to be due to inhibition of protein and/or DNA methyla-
tion reactions (37,38). The specific target of SNF in T.gondii is
unknown; however, it is a potent inhibitor of parasite growth
in vitro and mutants are readily isolated following chemical
mutagenesis (39). Our results map SNF resistance to a locus
near AK123 on chromosome IX (Table 3, Figures 2 and 3).
Although SNF has the highest LOD score with AK123
(Table 3), this marker is located at the same genetic position
with three others markers AK60, AK124, MIC1. Collectively,
these markers span 540 kb in physical size, thus limiting
our ability to precisely map the gene responsible for SNF
resistance.
The anti-coccidial compound arprinocid is converted to
arprinocid-N-oxide (ANO), which is significantly more potent
at inhibiting the parasite than the parental compound (40). The
mechanism of action of this anti-coccidial drug is presently
unknown and our mapping results indicate ANO resistance
was linked to chromosome XI along with resistance to FUDR.
Unfortunately, the biased nature of the alleles in T.gondii
makes it impossible to localize this linkage precisely since
there is only one informative marker for the II · III lineages
on this chromosome (AK155B). Resistance to ANO matched
this marker exactly and was also identical to the pattern of
FUDR resistance for the c96 clones. However, this does not
indicate that these two compounds share the same target and
in fact other clones that were FUDR resistant (derived from
the I · III cross where arprinocid was not used) were fully
sensitive to ANO (data not shown).
Mapping the genome scaffolds to chromosomes
The recently completed 10X whole genome shotgun sequence
of the T.gondii genome was obtained from the type II strain
ME49 and it consists of670 scaffolds that range in size from
<6 kb to >5 Mb (http://toxodb.org/ToxoDB.shtml). However,
the absence of a physical map has hampered the assembly of
the genome into chromosomes. Based on the segregation of
genetic markers, we were able to assign 63 of the largest
scaffolds (Table 4) to specific groups and to order these
scaffolds along the chromosomes (Figure 4). The orientation
Figure 3. Mapping of drug resistance to SNF, FUDR and ARA-A across the
genome of T.gondii. Plots indicate the log-likelihood association of resistance
to each drug with markers aligned across the genome. In each case, a single
locus was found to be statistically associated with resistance, and apparent
secondary peaks were either non-significant or in non-informative regions
of segregation distortion. Resistance to SNF was localized to chromosome
IX, FUDR was localized to XI and ARA-A was mapped onto chromosome
XII. Plots were generated from genome-wide scans using permutation analysis
for marker associations from I · III crosses. Significance levels are given by
dotted lines [lower line is significant (log likelihood of 1.7) while the upper line
is highly significant (log likelihood of 3)].
Table 3. Mapping of drug resistance in genetic crosses of T.gondii
Drug resistance Chromosome Closest marker LOD scorea Log likelihoodb
FUDR XI UPRT 9.33 7.34
ARA-A XII AK 9.33 6.62
SNF IX AK123 21.37 6.77
aLOD scores were calculated using MapManager QTX (23).
bLog-likelihood statistic was determined by permutation analysis. Both
analyses were based on phenotypes derived from I · III crosses.
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of many of these scaffolds follows directly from the genetic
linkage maps (green bars in Figure 4). The resulting 14 chro-
mosomes ranged in size from 1.8 (chromosome Ia) to >7 Mb
(chromosome X). In addition to mapping scaffolds by link-
age studies, we also identified the physical locations of BAC
clones whose paired end sequences were generated by the
Wellcome Trust Sanger Institute (http://www.sanger.ac.uk/
Projects/T_gondii/). The majority of BAC clones (1555 of
1616) were entirely contained within an existing genomic
scaffold. The distances between the ends were found to
have a bimodal distribution of lengths with two peaks at
18–20 kb and at 60–80 kb (Supplemental Figure 1). Among
the remaining 61 clones, many BAC clones bridged the phys-
ical gaps between scaffolds that had already been mapped and
oriented by genetic linkage analysis, confirming the genetic
chromosomal assembly (green bars connected by horizontal
lines in Figure 4). In some cases, the location of a BAC clone
provided orientation for adjacent scaffolds that were genetic-
ally linked, but whose end-to-end orientation was uncertain
(light purple bars in Figure 4). Furthermore, a small number of
BAC clones supported the inclusion of several smaller scaf-
folds within the chromosomal linkage groups. Additional gen-
etic markers were developed within these smaller scaffolds
and their chromosomal location confirmed by linkage analysis.
While BAC clones tied together the majority of physical scaf-
folds for some chromosomes (i.e. II, III, IV, VIIa and XII),
some scaffolds remain linked only by genetic data. In a few
cases, the small size of scaffolds or low recombination rate
between adjacent markers (e.g. chromosome V) made it
impossible to correctly predict their orientation (yellow bars
in Figure 4). In total, the resulting genome map represents
61.6 Mb in size, which corresponds to 95% of the estimated
genome size of 65 Mb. A relatively large number (600) of
small scaffolds remain and most are <10 kb in size. The scaf-
folds cannot be assembled into the genome either due to low
quality sequence or repeats and they are also well below the
Table 4. Number and sizes of 10X whole genome sequence scaffolds that were
mapped
Sizes of scaffoldsa (bp) Number of scaffolds Sizes (bp)
<100 000 18 604 560
100 000–300 000 11 2 007 756
300 000–500 000 9 3 484 114
500 000–001 000 000 5 3 761 563
1 000 000–002 000 000 12 17 981 672
>2 000 000 9 33 805 833
Total 63 61 645 498
aScaffold numbers were based on ToxoDB (http://toxodb.org/ToxoDB.shtml),
a complete list of the scaffolds that were mapped can be found at http://
ToxoMap.wustl.edu/.
Figure 4. Horizontal maps of the genome scaffolds comprising each of the T.gondii chromosomes. Chromosome numbers are indicated to the left as is the total size of
scaffolds in base pairs. Scaffold numbers are given within or above the colored bars. Bars colored green indicated scaffolds that were mapped and oriented by linkage
analysis. Bars indicated in light purple were linked genetically and oriented by BAC-end data. There are several remaining scaffolds that are linked by genetic data but
where the orientation is still unknown (yellow bars). There are also five scaffolds that are linked only by BAC-end data (blue bars). Orientations that were supported
by BAC-end data are indicated by a thin horizontal line connecting the bars.
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mapping resolution of linkage analysis. Thus, they are not
presently incorporated into the genome map.
Genetic parameters of T.gondii
The genetic map of T.gondii reported here consists of a total of
592 cM. Based on an estimated genome size of65 Mb, this
corresponds to an average of 104 kb/cM. The genetic sizes
of specific chromosomes were roughly correlated with their
physical sizes as shown in Figure 5A. By placing the genetic
markers along the physical map provided by the 10X scaffolds,
we were also able to estimate the rate of recombination across
different chromosomes and specific regions of the genome. As
is typically seen in eukaryotic organisms, the rate of recomb-
ination versus physical distance varied somewhat across the
chromosomes ranging from a high of 42 kb/cM (chromosome
Ia) to a low of >155 kb/cM (chromosome VIIb) (Table 2). This
variation is statistically significant, since the overall distribu-
tion of crossover counts and locations deviated markedly a
single genome-wide Poisson model. However, using separate
estimates of Poisson parameters for each chromosome
provided a good fit to the data.
One notable feature, which has previously been found in
P.falciparum (26), is that the frequency of apparent double
recombination events encompassing only single markers
greatly exceeds the expected rate of closely spaced double-
crossovers. We analyzed the occurrence of these ‘single-
marker events’ (i.e. progeny haplotypes like hhahh and
aahaa) and all double-crossovers separated by more than
one marker on each of the chromosomes of T.gondii. In
addition to classifying events according to the number of
intervening genetic markers, we estimated the ranges of phys-
ical distance separating the crossover locations and compared
these with theoretical models (see Materials and Methods). We
carefully checked all single-marker events by re-genotyping
the relevant progeny at the pertinent marker and flanking
markers.
As shown in Figure 5B, the frequencies of single-marker
events that are estimated to span short physical distances were
very significantly in excess of the double crossover frequen-
cies predicted by the models (light gray sections of the two left
hand bars, P = 0.00015 and 0.011). This excess amounts to
19–20 single-marker events. In contrast, the events with
longer spacings showed no significant differences from the
expected frequency of double-crossovers: these include the
five single-marker events in the third and fourth bars from
left in Figure 5B which have widely spaced flanking markers.
The general agreement between the observed distribution
of double-crossovers spanning two or more markers and the
Poisson/uniform models suggests that generalized positive or
negative crossover interference is not detectable in these
crosses. Therefore, single-marker events could be attributable
either to small local clusters of crossovers (‘hotspots’) or to
local non-reciprocal meiotic gene conversions. Hotspots are
evident in two locations where an identical single-marker
event is present in two or more independent progeny (the
events spanning markers AK57 and SAG3 on chromosomes
II and XII, respectively). However, the majority of the excess
single-marker events are likely to reflect gene conversions, as
suggested for P.falciparum (26) and consistent with the mei-
otic mechanisms known in other eukaryotes. In support of the
conversion hypothesis, if these conversion candidates are
excluded from the theoretical prediction, the model gives
an improved fit to the distribution of all double-crossovers
spanning two or more markers (lower line, Figure 5B).
CMap database
To provide a dynamic interface for comparing the genetic
maps with the underlying physical scaffolds, we have
A B
Figure 5. Recombination frequency for T.gondii chromosomes and analysis of double-crossovers. (A) The genetic size of chromosomes was roughly correlated with
their physical sizes as determined by summing the scaffolds for each chromosome shown in Figure 2. (B) Double-crossover analysis suggests that gene conversion
processes in addition to double-crossovers contribute to recombination events spanning a genome segment containing only a single genetic marker. Vertical black
bars show numbers, for all 71 progeny, of double-crossovers that are separated by two or more genetic markers, plotted versus estimated physical distance ranges
separating the two crossovers (see Materials and Methods). Light gray sections of the four left bars represent additional recombination events spanning only one
genetic marker (‘single-marker events’). As shown by the P-values and theoretical lines, the single-marker events in the two left bars are unlikely to occur by chance
from the frequencies of true double-crossovers predicted by Poisson/uniform models (see Materials and Methods). The lines represent alternative models where
dotted line indicates all cases, including all single-marker events, are assumed to be true double-crossovers and solid line indicates single-marker events in the two left
bars are excluded from the numbers of double-crossovers.
2988 Nucleic Acids Research, 2005, Vol. 33, No. 9
 at W
ashington University School of M
edicine Library on July 17, 2011
n
a
r.o
xfordjournals.org
D
ow
nloaded from
 
developed a CMap database for representing genetic linkage
maps based on the Genetic Model Organisms Database
(GMOD) (http://www.gmod.org/). CMap for T.gondii con-
tains the genetic linkage maps, physical placement of markers
along the scaffolds, and corresponding relationships between
the physical and genetic maps (http://ToxoMap.wustl.edu/
cmap/). To illustrate the utility of this database, we have gen-
erated a composite image of chromosome III showing the
markers present on each scaffold and their correspondence
to the genetic map (Figure 6). This figure illustrates the dis-
tribution of markers across the physical scaffold with spacing
of 300 kb and illustrates how the map unit varies substan-
tially across the chromosome from 2 to >100 kb/cM. As
well, this map illustrates the anchoring of some scaffolds
using the BAC-end clones (dumbbell symbol in Figure 6),
which gives added confidence to linkages between adjacent
scaffolds where the map unit is highly variable. We have also
incorporated all of the genetic markers into the GBrowse
application of the genetic model organism database suite
(http://www.gmod.org/) that has been established for the
T.gondii genome (http://toxodb.org/cgi-bin/gbrowse).
GBrowse for T.gondii also contains all of the predicted
open reading frames (ORFs), gene prediction models, ESTs
and BLAST homologies for the T.gondii genome. The com-
bination of the CMap and GBrowse databases will make it
possible to readily connect phenotypic information on specific
genetic linkages to genes in the underlying genome.
DISCUSSION
Apicomplexan life cycles typically involve both sexual and
asexual stages, yet rarely has this been exploited to develop
genetic tools, largely due to the intractability of many of these
organisms. Genetic linkage maps have been generated for
several other apicomplexan parasites including the human
malarial parasite P.falciparum (26), the rodent malarial para-
site P.chabaudi (41) and the avian coccidian Eimeria tenella
(42). Genetic studies have been useful in these organisms for
mapping drug resistance as well as for studying complex
phenotypes such as invasion and development (31,41–43).
Previous studies in T.gondii have also revealed the potential
for genetic mapping to identify quantitative trait loci for com-
plex phenotypes such as virulence (15). Here, we extend this
analysis by generating a high-resolution linkage map and
using it to assemble the sequence scaffolds from the recently
completed whole genome shotgun sequence of T.gondii. The
resulting genome map provides a framework for expanded
studies on the genetic basis of complex biological traits
such as drug resistance, infectivity and transmission.
Figure 6. Genetic and physical maps for chromosome III as drawn from CMap for T.gondii. CMap representation of the genetic map (left), scaffolds (center) and the
assembled chromosome (right) for T.gondii chromosome III. Correspondences are shown in colored lines depicting the relationship between the data. Green lines
indicate markers that were mapped and oriented genetically. Purple lines indicate markers that were mapped genetically and oriented by BAC-ends. As well, BAC-
end linkages are indicated by blue horizontal dumbbell shaped bars. The scale for the left-hand map is based on genetic units, while the center and right-hand maps are
based on physical size in base pairs. Differences in the map unit across the various nodes of the genetic map are indicated at the far left in kb/cM.
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Members of the genus Plasmodium and Eimeria both have
14 major linkage groups. In the present study, 12 distinct
groups were identified for T.gondii based on linkage analysis
and combined with data on the physical separation of the
chromosomes, it is likely that there are actually 14 chromo-
somes. In a previous version of the T.gondii genetic map, 11
chromosomes were identified in T.gondii based on a combina-
tion of linkage studies (15) and molecular karyotyping (30).
We detected the same 11 linkage groups characterized previ-
ously and also identified three new chromosomes. The previ-
ous absence of these chromosomes can be attributed to the
previously low coverage of RFLP markers, combined with the
fact that several of the new groups (IX and XII) were too large
to enter pulse-field gels. The combined genome map contains
50 gaps between adjacent scaffolds, 29 of which are linked by
BAC clones. These BAC clones thus provide approximate size
estimates and possible templates for future efforts to close the
remaining gaps.
While nearly all of the markers were placed unambiguously
to a single chromosome, there was a region of unexpected
strong linkage between chromosomes VIIb and VIII, solely
attributable to the results of I · III cross. A physical associ-
ation between these chromosomes is not consistent with scaf-
fold position as established from the assembly of the type II
strain ME49 genome or physical hybridization of markers
from VIIb and VIII. Despite previous studies indicating an
equal likelihood of self-fertilization versus cross-fertilization
(13,39), we observed that nearly all clones isolated from
I · III cross were genetic recombinants, even when not selec-
ted by drug resistance markers. Each of the parental strains
used in this cross is individually capable of self-fertilization
(data not shown), indicating that this result is not due to oblig-
atory cross-fertilization. Thus, our findings could be explained
by selective pressure for recombination among the clones that
grew out from this cross, resulting in the apparent linkage
between chromosomes VIII and VIIb. It is also possible
that VIIb and VIII are physically joined in the type I GT1-
F3 parent, but not in the type II or type III lineages. The
absence of polymorphisms between the type II and III lineages
makes it impossible to accurately predict the behavior of chro-
mosome VIII in some genetic crosses. Therefore, additional
genetic crosses (i.e. between types I and II lineages) will be
needed to resolve this issue.
The utility of genetic linkage studies for identifying genes
that mediate specific phenotypes is determined largely by the
meiotic recombination frequency, which is typically expressed
as a map unit (cM) representing the region across which there
is a 1% chance of recombination. Despite having a similar
complexity in terms of number of genes, the rate of recomb-
ination in T.gondii is6 times lower than P.falciparum. Thus,
while Plasmodium has an average physical distance per
recombination unit of 17 kb/cM (26), the corresponding
value is 104 kb/cM for T.gondii. The average map unit in
T.gondii varied by up to 3-fold between separate chromo-
somes, although greater local variation was occasionally
noted. The relatively large map unit in T.gondii means that it
is straightforward to map a particular phenotype to a general
region of one of the chromosomes. The current resolution of
the map allows mapping of a trait to a genomic region of 200–
500 kb, depending on the location. For example, genes encod-
ing SNF, FUDR and ARA-A resistance were mapped to loci
on chromosome IX, XI and XII, respectively (Figures 2 and 3).
While the genes conferring resistance to FUDR and AK were
previously known, the target of SNF was not. Our analysis
places this gene within a region that comprises 500 kb on
chromosome IX, bounded by the markers AK123 and MIC1.
Because >95% of the genome sequence is now assembled and
ordered into scaffolds that correspond to the genetic map, it is
possible to identify the underlying genes using a combination
of CMap and GBrowse. Such analysis indicates there are
60–70 genes within this region and it is likely that a single
mutation in one of them is responsible for the resistance
phenotype.
Positional cloning of drug resistance loci could be accomp-
lished by linkage analysis of further recombinant progeny.
While increasing the overall precision of the map might
require 5–10 times the number of progeny, finer mapping
on a local scale could be achieved with far fewer clones,
particularly if they are chosen for recombinations across spe-
cific regions of the genome. This can readily be achieved by
PCR-based screening on 96-well plate cultures, allowing the
screening of hundreds of potential clones. It is estimated that a
single cross can generate >107 oocysts, making the upper limit
of recombinant clones quite high. It is possible to cryopreserve
the progeny of a single cross as an uncloned population for
future efforts aimed at isolation of additional clones. Ulti-
mately, positional cloning will still be limited by the relatively
low recombination rate in T.gondii; however this approach is
complementary to reverse genetic approaches that are also
well-developed in T.gondii (3).
Like malaria (26), T.gondii exhibited a high frequency of
closely spaced apparent double-crossovers. This phenomenon
has been associated with gene conversion events, rather than
reciprocal exchanges in other systems (26). While we have not
directly determined the mechanism by which these events
occurred (i.e. true-double crossovers versus gene conversions)
in T.gondii, their presence has significance for mapping pheno-
types by linkage analysis: intervals spanning quantitative trait
loci, for example, can be rigorously delimited only by cros-
sovers but not by non-reciprocal conversions. If single-marker
events do represent gene conversions, there were probably
many more conversions that were not detected by the current
density of markers. Consequently, it may be advantageous to
increase the density of the markers as well as the numbers of
progeny as a means of improving the resolution for mapping
complex traits.
One highly unusual feature of the T.gondii genome is the
asymmetric distribution of strain-specific SNPs. In order to
illustrate this, we have color-coded each SNP mapped here
based on the strain type where the unique difference is
observed (red = type I, green = type II and blue = type III
in Figure 2). Several chromosomes present remarkably homo-
geneous patterns. For example, chromosome IV is almost
entirely made up of type III-specific SNPs, likewise chromo-
some XI is primarily type I. On some chromosomes, this
occurs as a marked bias toward one end (distal portions of
chromosomes III, VIIb and XII are primarily type I). These
regions of homogeneous polymorphism were interspersed
with the majority of regions that show mixed patterns of
SNPs. The reason for these differing patterns is uncertain,
but they suggest that large-scale regions of the genome
have experienced relatively little recombination with respect
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to the ancestral biallelic pattern of T.gondii (8,9). Importantly,
the behavior of these nonhomogeneous regions did not differ
from that of the rest of the genome in the experimental crosses.
While some showed enhanced levels of recombination at the
transition from fixed to variable polymorphism (i.e. markers
AK97–AK39 on chromosome III, Figures 2 and 6), most of
these regions did not. A more global analysis of the distribu-
tion of SNPs across the genome has detected a similar pattern
(Jon Boyle and John Boothroyd, unpublished data; http://
boothroydlab.stanford.edu/snp_maps/) and resolving the
importance of these patterns awaits further investigation.
We report here on a combined genome map for T.gondii
consisting of 14 chromosomes ranging in size from slightly
<2 to >7 Mb. We have placed 250 markers at300 kb intervals
across the map, thus connecting the genetic linkage maps with
the major scaffolds from whole genome sequence. The present
genome map provides excellent coverage for most regions, and
any current deficiencies could be corrected by future genetic
crosses between the type I and II lineages that would provide
informative markers for the fallow regions that show strong
SNP bias. Future efforts at increasing the density of markers
on the map will also provide greater resolution for mapping
complex traits that differ between the lineages such as drug
resistance, virulence, transmission and development.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at NAR Online.
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